Copyright: ©Author(s) 2026.
World J Clin Pediatr. Dec 9, 2026; 15(4): 122880
Published online Dec 9, 2026. doi: 10.5409/wjcp.122880
Published online Dec 9, 2026. doi: 10.5409/wjcp.122880
Table 1 Clinical characteristics of children included in the study, n (%)/mean ± SD
| Clinical characteristics | Total (n = 176) | Asthma with eosinophilia | P value | |
| Yes (n = 84) | No (n = 92) | |||
| Age (year) | 8.2 ± 1.1 | 8.3 ± 0.8 | 8.11 ± 1.1 | 0.21 |
| Male | 99 (56.4) | 48 (57.2) | 51 (55.4) | 0.82 |
| BMI (kg/m2) | 21.1 ± 1.8 | 20.9 ± 1.9 | 21.6 ± 1.7 | 0.28 |
| Allergic rhinitis | 68 (38.6) | 37 (44.1) | 31 (33.7) | 0.16 |
| Atopic dermatitis | 13 (7.4) | 7 (8.3) | 6 (6.5) | 0.64 |
| Duration of asthma (year) | 1.9 ± 0.7 | 1.8 ± 0.8 | 2.1 ± 0.3 | 0.13 |
| Family history of atopy | 61 (34.7) | 33 (39.3) | 28 (30.4) | 0.22 |
Table 2 Severity of asthma based on blood eosinophilia, n (%)
| Parameters | Total (n = 176) | Asthma with eosinophilia | OR1/MD (95%CI) | P value | |
| Yes (n = 84) | No (n = 92) | ||||
| Asthma control (ACT score < 20) | 75 (42.6) | 43 (51.2) | 32 (34.8) | 1.97 (1.07, 3.6) | 0.027 |
| Asthma severity | |||||
| Intermittent | 54 (30.7) | 26 (31.0) | 28 (30.4) | 1.02 (0.54, 1.95) | 0.94 |
| Mild | 41 (23.3) | 19 (22.6) | 22 (23.9) | 0.93 (0.46, 1.87) | 0.83 |
| Moderate | 68 (38.6) | 39 (46.4) | 29 (31.5) | 1.88 (1.02, 3.48) | 0.041a |
| Severe | 13 (7.4) | 10 (11.9) | 3 (3.3) | 4.01 (1.06, 15.11) | 0.02a |
| Spirometry values, mean ± SD | |||||
| FEV1 (% predicted) | 74.5 ± 19.1 | 72.6 ± 17.7 | 76.9 ± 16.5 | -4.3 (-9.4, 0.8) | 0.18 |
| FVC (% predicted) | 88.6 ± 17.9 | 88.1 ± 18.2 | 89.5 ± 17.3 | -1.4 (-6.7, 3.9) | 0.58 |
| FEV1/FVC ratio (%) | 68.3 ± 10.4 | 65.5 ± 10.3 | 69.7 ± 9.9 | -4.2 (-7.1, -1.3) | 0.006a |
Table 3 Serum total immunoglobulin E level (kIU/L), n (%)
| Serum total IgE level (kIU/L) | Total (n = 93) | Asthma with blood eosinophilia | OR (95%CI) | P value | |
| Yes (n = 50) | No (n = 43) | ||||
| Absolute level, median (IQR) | 202 (68-376) | 295 (112-487) | 98 (54-219) | - | < 0.001a |
| Cut-off levels | |||||
| > 100 to ≤ 300 | 40 (43) | 25 (50) | 15 (34.9) | 1.87 (0.81, 4.31) | 0.14 |
| > 300 | 28 (30.1) | 20 (40) | 8 (18.6) | 2.92 (1.12, 7.57) | 0.024a |
Table 4 Multivariate analysis of factors for asthma with blood eosinophilia
- Citation: Das RR, Panigrahi MK, Mahapatro S, John J. Clinical and functional correlates of blood eosinophilia in pediatric asthma: A retrospective cohort study. World J Clin Pediatr 2026; 15(4): 122880
- URL: https://www.wjgnet.com/2219-2808/full/v15/i4/122880.htm
- DOI: https://dx.doi.org/10.5409/wjcp.122880